Clinically validated for
HR+, HER2-, N0/N1, early-stage breast cancer patients
HR+, HER2-, N0/N1, early-stage breast cancer patients
The Patient Profile Navigator will provide you with N0 and N1 clinical data to help you decide whether an Oncotype DX® test would aid in making these important decisions.
With some clicks you can:
- Choose your clinical pathological parameter/s of interest
- Browse through clinical data
- Get in contact with an Exact Sciences representative
